![Shirley Hollander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 467 065 $ am 31.05.2026
Shirley Winkler Hollander is Chief Financial Officer & Executive Director at iFOREX Financial Trading Holdings Ltd. starting in 2025.
Former roles include Finance Director at Stk Bio-Ag Technologies from 2021 to 2024, Associate Director-Accounting at Teva Pharmaceuticals Ltd. (Israel) from 2017 to 2021, and Assurance Manager at Ernst & Young (Israel) Ltd. from 2010 to 2017.
Education includes an undergraduate degree from Ben-Gurion University of the Negev.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,78 % | 16.03.2026 | 175 000 ( 0,78 % ) | 467 065 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|
| Unternehmen | Position | Ende |
|---|---|---|
Stk Bio-Ag Technologies | Finanzdirektor/CFO | 01.07.2024 |
Teva Pharmaceuticals Ltd. (Israel) | Comptroller/Controller/Auditor | 01.06.2021 |
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01.09.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young (Israel) Ltd.
Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Stk Bio-Ag Technologies | |
Teva Pharmaceuticals Ltd. (Israel) |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
